Exercise oxidative skeletal muscle metabolism in adolescents with cystic fibrosis

Experimental Physiology

Volumn 101, Issue 3, 2016, Pages 421-431

  Werkman, Maarten ^a   Jeneson, Jeroen ^a   Helders, Paul ^a   Arets, Bert ^a   van der Ent, Kors ^a   Velthuis, Birgitta ^b   Nievelstein, Rutger ^b   Takken, Tim ^a,c   Hulzebos, Erik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Partner of Shared Utrecht Pediatric Exercise Research (SUPER) Lab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE PHOSPHATE; HEMOGLOBIN; PHOSPHATE; OXYGEN;

ADOLESCENCE; ADULT; AEROBIC METABOLISM; ARTICLE; BACTERIAL COLONIZATION; BICYCLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE SEVERITY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEAN BODY WEIGHT; LEG MUSCLE; MALE; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGENATION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; QUADRICEPS FEMORIS MUSCLE; REST; SCHOOL CHILD; WORKLOAD; ADOLESCENT; BODY COMPOSITION; BODY MASS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE;

ADOLESCENT; BODY COMPOSITION; BODY MASS INDEX; CYSTIC FIBROSIS; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEMOGLOBINS; HUMANS; MALE; MUSCLE, SKELETAL; OXYGEN; OXYGEN CONSUMPTION; PHOSPHOCREATINE; REST;

EID: 84959449965     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085425     Document Type: Article

References (36)

1. Almajed A & Lands LC (2012). The evolution of exercise capacity and its limiting factors in cystic fibrosis. Paediatr Respir Rev 13, 195-199.
2. Bongers BC, de Vries SI, Helders PJM & Takken T (2013). The steep ramp test in healthy children and adolescents: reliability and validity. Med Sci Sports Exerc 45, 366-371.
3. de Meer K, Jeneson JAL, Gulmans VAM, van der Laag J & Berger R (1995). Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 50, 980-983.
4. Divangahi M, Balghi H, Danialou G, Comtois AS, Demoule A, Ernest S, Haston C, Robert R, Hanrahan JW, Radzioch D & Petrof BJ (2009). Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 5, e1000586.
5. Erickson ML, Seigler N, McKie KT, McCully KK & Ryan AH (2015). Skeletal muscle oxidative capacity in patients with cystic fibrosis. Exp Physiol 100, 545-552.
6. Evans AM, Hardie DG, Peers C & Mahmoud A (2011). Hypoxic pulmonary vasoconstriction; mechanisms of oxygen sensing. Curr Opin Anesthesiol 24, 13-20.
7. Fischer R, Simmerlein R, Huber RM, Schiffl H & Lang SM (2007). Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 42, 1193-1197.
8. Habers GEA, de Knikker R, van Brussel M, Hulzebos E, Stegeman DF, van Royen A & Takken T (2013). Near-infrared spectroscopy during exercise and recovery in children with juvenile dermatomyositis. Muscle Nerve 47, 108-115.
9. Harms CA, Babcock MA, McClaren SR, Pegelow DF, Nickele GA, Nelson WB & Dempsey JA (1997). Respiratory muscle work comprises leg blood flow during maximal exercise. J Appl Physiol 82, 1573-1583.
10. Hebestreit H, Hebestreit A, Trusen A & Hughson RL (2005). Oxygen uptake kinetics are slowed in cystic fibrosis. Med Sci Sports Exerc 37, 10-17.
11. Hjeltnes N, Stanghelle JK & Skyberg D (1984). Pulmonary function and oxygen uptake during exercise in 16 year old boys with cystic fibrosis. Acta Paediatr Scand 73, 548-553.
12. Jeneson JAL & Bruggeman FJ (2004). Robust homeostatic control of quadriceps pH during natural locomotor activity in man. FASEB J 18, 1010-1012.
13. Jeneson JAL, Schmitz JPJ, Hilbers PAJ & Nicolay K (2010). An MRI-compatible bicycle ergometer for in-magnet whole body human exercise testing. Magn Reson Med 63, 257-261.
14. 31P MRS assay of mitochondrial function in skeletal muscle in situ. Mol Cell Biochem 174, 17-22.
15. Jeneson JAL, Wiseman RW, Westerhoff HV & Kushmerick MJ (1996). The signal transduction function for oxidative phosphorylation is at least second order in ADP. J Biol Chem 271, 27995-27998.
16. Lamhonwah AM, Bear CE, Huan LJ, Kim Chiaw P, Ackerley CA & Tein I (2010). Cystic fibrosis transmembrane conductance regulator in human muscle dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 67, 802-808.
17. Mancini D (1997). Application of near-infrared spectroscopy to the evaluation of exercise performance and limitations in patients with heart failure. J Biomed Opt 2, 22-30.
18. Meyer RA (1988). A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol Cell Physiol 254, C548-C553.
19. Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R & Cooper DM (2000). Muscle size and cardiorespiratory response to exercise in cystic fibrosis. Am J Respir Crit Care Med 162, 1823-1827.
20. Nixon PA, Orenstein DM, Kelsey SF & Doershuk CF (1993). The prognostic value of exercise testing in patients with cystic fibrosis. Chest 104, 1490-1497.
21. Portney LG & Watkins MP (2009). Foundations of Clinical Research: Applications to Practice. Pearson Education, Inc., Upper Saddle River, New Jersey.
22. Pressler T, Bohmova, Conway S, Dumcius S, Hjelte L, Høiby N, Kollberg H, Tümmler B & Vavrova V (2011). Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros 10, 75-78.
23. Prompers JJ, Jeneson JAL, Drost MR, Oomens CC, Strijkers GJ & Nicolay K (2006). Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed 19, 927-953.
24. Rosenthal M, Narang I, Edwards L & Bush A (2009). Non-invasive assessment of exercise performance in children with cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis: is there a CF specific muscle defect? Pediatr Pulmonol 44, 222-230.
25. Savi D, Di Paolo M, Simmonds N, Onorati P, Internullo M, Quattrucci S, Winston B, Laveneziana P & Palange P (2015). Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis. BMC Pulm Med 15, 59.
26. Saynor ZL, Barker AR, Oades PJ & Williams CA (2014). Impaired aerobic function in patients with cystic fibrosis during ramp exercise. Med Sci Sports Exerc 46, 2271-2278.
27. Selvadurai H, McKay KO, Blimkie CJ, Cooper BJ, Mellis CM & van Asperen PP (2002). The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 165, 762-765.
28. Tzika AA, Constantinou C, Bandyopadhaya A, Psychogios N, Lee S, Mindrinos M, Martyn JA, Tompkins RG & Rahme LG (2013). A small volatile bacterial molecule triggers mitochondrial dysfunction in murine skeletal muscle. PLoS ONE 8, e74528.
29. Valdivieso AG, Clauzure M, Marín MC, Taminelli GL, Massip Copiz MM, Sánchez F, Schulman G, Teiber ML & Santa-Coloma TA (2012). The mitochondrial complex 1 activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function. PLoS ONE 7, e48059.
30. Van de Weert-van Leeuwen PB, Arets HGM, van der Ent CK & Beekman JM (2013). Infection, inflammation and exercise in cystic fibrosis. Respir Res 14, 32.
31. Van de Weert-van Leeuwen PB, Slieker MG, Hulzebos HJ, Kruitwagen CL, van der Ent CK & Arets HG (2012). Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J 39, 893-898.
32. 2 levels cause mitochondrial dysfunction and impair cell proliferation. J Biol Chem 286, 37067-37076.
33. Wells GD, Wilkes DL, Schneidermann JE, Rayner T, Elmi M, Selvadurai H, Dell SD, Noseworthy MD, Ratjen F, Tein I & Coates AL (2011). Skeletal muscle metabolism in cystic fibrosis and primairy ciliary dyskinesia. Pediatr Res 69, 40-45.
34. Wells GD, Wilkes DL, Schneidermann-Walker J, Elmi M, Tullis E, Lands LC, Ratjen F & Coates AL (2008). Reliability and validity of the habitual activity estimation scale in patients with cystic fibrosis. Pediatr Pulmonol 43, 345-353.
35. Wu F, Jeneson J & Beard DA (2007). ATP synthesis in skeletal muscle is controlled by substrate feedback. Am J Physiol Cell Physiol 292, C115-C124.
36. Zapletal A, Samanek M & Paul T (1987). Lung function in children and adolescents: methods, reference values. In Progress in Respiration Research, Vol. 22, ed. Zapletal A, pp. 114-218. Karger, Basel.